Company / Current Assets
Vericel Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$247.4M
FY2025
5-year range
$158.5M / $247.4M
FY2021-FY2025
Trend
+16.3%
vs FY2024
Sector context
#178 of 213
Health Care
What the data says
Vericel's current assets of $247M is lower than 84% of companies in the Health Care sector (FY2025). Current Assets has increased for 6 consecutive years, from $112M in FY2019 to $247M in FY2025.
Based on SEC 10-K filings.
$247M in FY2025 with a 5-year CAGR of +14.9%.
Improved from $206M to $247M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +9.8%
- 5-Year CAGR
- +14.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 213This company $247.4M Sector average $2.5B
▼
-90.2% below sector average
Key checks
Key Insights
- Vericel's current assets has grown for 6 consecutive years.
- 5-year CAGR of +14.9%, indicating consistent growth.
- In FY2025, current assets increased 16.3% year-over-year.
- Ranks #178 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $247.4M | +16.3% |
| FY2024 | $212.8M | +3.5% |
| FY2023 | $205.6M | +10.0% |
| FY2022 | $186.9M | +17.9% |
| FY2021 | $158.5M | +28.2% |
| FY2020 | $123.6M | +10.7% |
| FY2019 | $111.7M | -1.0% |
| FY2018 | $112.8M | +123.3% |
| FY2017 | $50.5M | +12.9% |
| FY2016 | $44.7M | +63.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026